Hypoglycemia

This year is the first that I did not write a post on the weekend of the biannual daylight savings time change since the launch of this blog. In each earlier post, I aimed to raise awareness about health risks due to the time change.

Making people with diabetes the center of all aspects of diabetes management is the focus of a new position statement published by the Endocrine Society.

Hypoglycemia was not associated with later neurodevelopmental outcomes for children born late preterm, according to findings presented at The Pregnancy Meeting.

Once-weekly combination therapy of basal insulin icodec and semaglutide was noninferior to insulin glargine plus insulin aspart for lowering HbA1c among adults with type 2 diabetes, according to topline results from a phase 3a trial.

A form of inhaled insulin has been available for adults with type 1 and type 2 diabetes for nearly a decade, but providers say many people are not aware that it may be a treatment option for them.

Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.

New guidance on obesity management and cardiovascular disease screening for people with diabetes are among the updates in the American Diabetes Association’s 2024 Standards of Care.

The new continuous glucose monitoring metric Glycemia Risk Index better assesses hypoglycemia risk than time in range, according to study data.

Children and adults using a hybrid closed-loop insulin delivery system had fewer cases of severe hypoglycemia and diabetic ketoacidosis than what was previously observed in historical data, according to study findings.

The FDA issued a warning for consumers to avoid using a nonprescription product currently being sold for blood glucose management due to risks for adverse events, according to an agency press release.